Lv4
704 积分 2022-12-02 加入
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond
3天前
已完结
Cancer incidence and mortality in China, 2024
1个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
1个月前
已完结
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
1个月前
已完结
IDF Global Clinical Practice Recommendations for Managing Type 2 Diabetes 2025
1个月前
已完结
Tirzepatide monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO)
1个月前
已完结
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
2个月前
已完结
Multidimensional Pancreatic Islet β-cell Function Assessment Improves Predictive Effect of Diabetes Risk Scores
2个月前
已关闭
Multidimensional Pancreatic Islet β-cell Function Assessment Improves Predictive Effect of Diabetes Risk Scores
2个月前
已完结
中国肥胖及2型糖尿病外科治疗指南(2019版)
2个月前
已完结
皖公网安备34019202002308
